Eli Lilly’s EPS slip 1% to $1.53 in Q2
Eli Lilly and Company revealed on Tuesday that its diluted earnings per share (EPS) declined by 1% compared to the same period a year prior, to stand at $1.53 in the second fiscal quarter of 2021.
Th…
Eli Lilly and Company revealed on Tuesday that its diluted earnings per share (EPS) declined by 1% compared to the same period a year prior, to stand at $1.53 in the second fiscal quarter of 2021.
Th…